OUR INSIGHTS
Featured Articles
How Healthcare and Life Sciences Companies Fail: The Sequence a Board Can Interrupt
Insolvency is the last stage of a sequence that starts in the boardroom. Directors who know the four stages, and where AI speeds them, can interrupt the sequence while options are still wide.
Continuity of Care and AI at the Hand-Off
Continuity of care has three parts, strong evidence behind it, and structural obstacles in the United States. AI now drafts many of the documents that carry it.
Precision Healthcare and Life Sciences: What Held Up and What Boards Should Learn
I listed ten precision healthcare trends in 2022. Some reached patients and some faded; the difference is the evidence path, and it is the test boards should apply to AI.